Immunophenotyping in Autoimmune Diseases and Cancer 

<br/><br/><br/>English[eng] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>CD8+CD28− T cells||cancer immunology||glioblastoma||immunotherapy||malignant glioma||cancer||accidental cell death||oncosis||DDR||parthanatos||flow cytometry||systemic lupus erythematosus||T cells||glycosylation||sialylation||lectin binding||glycosylation enzymes||galectin 1||choriocarcinoma||hydatidiform mole||galectin||gestational trophoblastic disease||placental-specific gene||systems biology||trophoblast differentiation||B cells||non-switched B cells||systemic sclerosis||dcSSc||TLR||CD180||RP105||CpG||IL-6||IL-10||natural autoantibodies||IgM||citrate synthase||DNA topoisomerase I||unfolded protein response||Inositol-requiring enzyme 1 (IRE1)||PKR-like endoplasmic reticulum kinase (PERK)||Glucose-regulated protein 78 (GRP78)||Activating transcription factor 6 (ATF6)||immune cells||T cell||macrophage||tumor microenvironment||single cell mass cytometry||metastatic breast cancer||myeloid-derived suppressor cells||immunophenotyping||breast cancer||trastuzumab||chimeric antigen receptor||cell therapy||neuroendocrine neoplasia||neuroendocrine tumor||neuroendocrine carcinoma||immunohistochemistry||syntaxin 1